CXCR4 and neoplasm: A similar peptide CXCR4 antagonist, CTCE-9908, significantly reduced the tumor burden in MDA-MB-231 breast cancer tumor-bearing mice and displayed a 20-fold reduction in metastasis compared to control [236].